Labeling of cerebral H1-receptors is obtained following i.v. administration of [3H]mepyramine in tracer dose as shown by saturability, stereospecificity, regional distribution and pharmacological specificity. Cerebral H1-receptors are occupied following administration of most H1-antihistamines at low therapeutic dosage, which probably accounts for the sedative side-effects of these agents.